U.S. stock futures were lower this morning, with the Dow futures falling more than 50 points on Monday.
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) fell sharply in today's pre-market trading after the announced completion and results of Phase 3 clinical program of AXS-05 in Alzheimer’s Disease Agitation.
Axsome Therapeutics shares fell 8.9% to $79.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
